METODOLOGY PAPER METODOLOŠKI RAD METODOLOGY PAPER METODOLOŠKI RAD SAŽETAK

Primarna bilijarna ciroza (PBC) je autoimunska bolest jetre koju karakteriše destrukcija intrahepatičnih žučnih kanalića i prisistvo antimitohondrijalnih antitela (AMAs). Poslednjih godina je razvijeno nekoliko mišjih modela PBC koji imaju slične serološke, biohemijske i histološke karakteristike kao i humana PBC. Ovi animalni modeli su omogućili ispitivanje etiologije i mehanizama uključenih u patogenezu PBC. U PBC imunski odgovor je usmeren na E2 komponentu 2-okso-kiseline dehidrogenaza familije enzima koji su locirani u mitohondrijama, a imunodominantni epitop je peptidna sekvenca sa lipidima koja je zajednička za ove enzime. Imunizacija miševa 2-oktinoičnom kisleinom vezanom za goveđi serumski albumin (2-OA-BSA), antigenom koji je strukturno sličan E2 subjedinici kompleksa piruvat dehidrogenaze (PDC-E2), omogućava razvoj histoloških promena koje karakterišu PBC kod ljudi. Ovaj model PBC indukovan ksenobiotikom je pogodan za ispitivanje početnih događaja u patogenezi PBC i za razvoj novih lekova za PBC.
INTRODUCTION
Primary biliary cirrhosis (PBC) is a liver-specific autoimmune disease (1) . PBC has a long latency period, which is followed by the development of common symptoms: fatigue, pruritus hyperpigmentation, and (in the terminal stages) bleeding varices, and ascites (2) . PBC is characterised by a multilineage humoral and cellular adaptive response against biliary epithelial cells (BECs) and destruction of small bile ducts by mechanisms that include innate immune responses (3; 4) . Bile duct destruction leads to cholestasis, fibrosis, and ultimately liver cirrhosis (4) . The typical characteristic of the disease is the presence of antimitochondrial autoantibodies (AMA), which are present in high amounts. The autoantigens to which the immune responese is directed in PBC has been identified as the E2 subunits of the 2-oxo-acid dehydrogenase complexes (2OADC-E2), including the E2 subunits of the pyruvate dehydrogenase complex (PDC-E2), branched chain 2-oxo acid dehydrogenase complex (BCOADC-E2), and 2-oxoglutarate dehydrogenase complex (OGDC-E2) (5) . The immunodominant autoantigen within this group is PDC-E2 (6; 7). A multi-faceted immune response to the immunodominant mitochondrial autoantigen PDC-E2 in PBC suggests that a loss of tolerance to PDC-E2 is the initiating event in the development of PBC; there is no significant evidence of epitope spreading, which is present in other autoimmune diseases (8) .
ETIOPATHOGENESIS OF PBC
The etiology of PBC, including the loss of tolerance, is still unknown. However, as in all autoimmune diseases, it is likely that genetic susceptibility and environmental factors play a role in the pathogenesis (9) . Environmental factors, including xenobiotics or microorganisms, modify the autoantigen and facilitate the breakdown of tolerance (10) .
Molecular mimicry: Cross-reactivity between sera of PBC patients and E. coli has been shown, but stronger reactivity (1,000-fold stronger than with E. coli) has been demonstrated with the xenobiotic-metabolising gramnegative bacterium Novosphingobium aromaticivorans (a bacterium present in human fecal specimens) (11) . N. aromaticivorans contains two proteins highly homologous to the immunodominant epitope of PDC-E2 and serum autoantibodies. Importantly, mice infected with N. aromaticivorans deveope PBC-like liver lesions (12) .
Xenobiotics: Because the liver plays a key role in the metabolism of toxins, the hepatocytes and BECs are continuously exposed to chemical by-products. Associations between PBC and the frequent use of nail polish support a xenobiotic pathogenesis hypothesis. 2-Octynoic acid is a food additive and xenobiotic that is present in cosmetic products, such as nail polish. The in vitro and in vivo data strongly support a potential role of 2-octynoic acid in PBC. Reactivity of 2-octynoic acid with AMAs and lipoic acid has been shown (13) . Congenic nonobese diabetic NOD.1101 (NOD.B6 Idd10 Idd18r2) C57BL/6 mice, immunised with 2-octynoic acid conjugated with bovine serum albumin, develop histological features of autoimmune cholangitis (portal infiltrates enriched in CD8+ cells and liver granulomas); these mice demonstrated high titers of AMAs (14) (15) (16) (17) . This model provides convincing evidence that xenobiotics are causally related to the development of PBC.
Biliary epithelial cells
The most intriguing aspect of the pathogenesis of PBC remains the specific immune response directed at the small intrahepatic bile ducts, as all nucleated cells have mitochondria with 2-oxo-acid dehydrogenase complexes. These small biliary ducts are lined with biliary epithelial cells, BECs (i.e., cholangiocytes) and are destroyed by the immune response, mediated by specific CD4+ and CD8+ T cells (18; 19) . This selective destruction indicates there are unique immunopathological characteristics of BECs. It is known that BECs are not passive bystanders in primary biliary cirrhosis; these cells can increase the expression of adhesion molecules and production of TNF-α, IFN-γ, and IL-1 upon stimulation with proinflammatory cytokines (20) . Through the variable expression of adhesion molecules and proinflamamtory cytokines, BECs can modulate the degree and localizisation of the inflammatory process. Additionally, BECs have properties of antigen presenting cells by expressing HLA class II and costimulatory molecules CD80 and CD86. Based on these characteristics of BECs, it can be hypothesizised that their interactions with T cells may be responsible for bile duct damage.
BECs of small bile ducts are very susceptible to apoptosis, more than epithelial cells of larger ducts (due to a lack of production of specific protease-resistant peptides, trefoils) (21) . Moreover, unique characteristics of apoptosis in BECs indicate that this process most likely plays a part in the immunopathogenesis of PBC. Autoreactive lymphocytes may be activated with neo-antigens arise from apoptotic BECs (22) . When BECs undergo apoptosis, the major mitochondrial autoantigen, PDC-E2, remains immunologically intact, whereas other cells following apoptosis present a form of PDC-E2 that cannot be detected by AMAs (23; 24) . Persistent exposure to PDC-E2, as derived from BECs, is caused by a failure to covalently link PDC-E2 to glutathione during the course of apoptosis in these cells. Another important observation regarding the role of apoptotic BECs in the pathogenesis of PBC is the high degree of proinflammatory cytokine production in monocyte-derived macrophages that was found in PBC patients who were incubated with apoptotic bodies from BECs (in the presence of AMAs) (25) . It is important to note that the BECs used in these experiments were derived from two normal donors, which implies that there is no phenotype of biliary epithelial cells specific for PBC; this could explain the recurrence of PBC following transplantation (26) .
Immunostaining of PBC biliary tract with monoclonal antibodies against mitochondrial autoantigens demonstrated a high degree of expression of PDC-E2 at the apical surface of the small bile duct cells lining the bile duct lumen (27; 28) . Cholangiocytes play a role in the transport of IgA antibodies in bile duct lumen. PDC-E2-specific IgA enters the BECs via a polyimmunoglobulin receptor and forms a complex with PDC-E2; it may thereby contribute to the exposure of PDC-E2 at the apical surface of BECs. Additionally, during transcytosis through cells expressing polyimmunoglobulin receptors, dimeric IgA can initiate the activation of caspases (29) . The levels of anti-PDC-E2 IgA antibodies in PBC sera directly correlate with the level of caspase activation.
IMMUNE RESPONSE IN PRIMARY BILIARY CIRRHOSIS
The mechanism of biliary destruction has not been completely determined, but the specificity of pathological changes in the bile ducts, the presence of lymphoid infiltration in the portal tracts, and the presence of majorhistocompatibility-complex class II antigens on the biliary epithelium indicate that an intense immune response is directed against the biliary epithelial cells. There are data suggesting that the destruction of biliary cells is mediated by liver-infiltrating autoreactive T cells (19; 30) . CD4+ and CD8+ T cells can be detected in the portal tracts of PBC patients (19; 31-33) . An increased serum level of autoantibodies specific for PDC-E2 is accompanied by a 100 times higher frequency of antigen-specific CD4+ T cells and a 10 times higher frequency of antigen-specific CD8+ T cells in liver as compared towith draining lymph nodes. Two important T helper cell subpopulations shown to have a role in the pathogenesis of PBC are Th17 and Treg cells (34) . Significantly lower levels of CD4+ CD25high are detected in the peripheral blood of PBC patients and their family members. In addition, FoxP3+ Treg cells can be detected in the lymphoid infiltrates found in the portal tracts (35) . Th17 cells have a pathogenic role in PBC: an increased frequency of IL-17-positive lymphocytes was found in liver tissues from patients with PBC, and in the IL-2Rα KO mouse model of autoimmune biliary disease (36) .
There is granulomatous inflammation in the liver of PBC patients that is accompanied by an increased production of polyclonal IgM antibodies. Cultured human BECs express toll like receptors (TLRs), lipopolysaccharide, and lipoteichoic acids, which are present in bile. The eExpression of TLRs in BECs is mediated through biliary injury via the NF-κB pathway (37) . In response to TLR stimulation, BECs may produce proinflammatory cytokines IL-6 and TNF-α and chemokines IL-8 and CX3CL1. CX3CL1 is a chemoattractant for cells expressing its receptor, CX3CR1. In PBC patients, CX3CR1 expressing CD8+ and CD4+ T cells can be found in the portal tracts and within the biliary epithelial layer of injured bile ducts (38) . Another cell type known to be involved in PBC pathogenesis are NKT cells. There is a higher frequency of CD1d-restricted NKTs in PBC patients. These cells are more frequently found in the liver than in the peripheral blood. An increased number of CD1d-restricted NKT cells was found in the liver of the dnTGF-βRII mouse model (39) . These CD1d-restricted NKT cells in the liver had increased IFN-γ production following exposure to α-galactosylceramide; this was accompanied by a decrease in hepatic lymphoid cell infiltration and less cholangitis when compared towith the controls.
ANIMAL MODELS OF PBC
Over the past several years, several animal models for PBC have been developed. Severe combined immunodeficient (SCID) mice develop lymphocytic infiltration around small bile ducts and present with the anti-PDC-E2 antibodies following the transfer of lymphocytes from peripheral blood of PBC patients (40) . Congenic NOD.c3c4 mice are obtained by replacing the diabetes-susceptibility genes on chromosomes 3 and 4 with the diabetes-resistance genes of B6 and B10 mice (41) . Overall, 50% to 60% of these mice develop autoimmune cholangitis and demonstrate AMA antibodies in their serum. Histologically, however, the cyst-like dilatation of the affected bile duct, which is characteristic of these mice, is not observed in PBC patients; when the dilatation becomes severe, the biliary epithelium of NOD.c3c4 mice frequently exfoliates, which can trigger neutrophil infiltration that is not characteristic of human disease. Another mouse model for PBC is the dnTGF-βRII mouse. These mice over express the dominant-negative form of TGF-β receptor II under the control of the CD4 promoter. A deficiency of TGF-β signalling causes various immunological abnormalities, including colitis. dnTGF-βRII mice exhibit major serological and histological characteristics of human PBC (42) , indicating an important role of the TGF-β signalling pathway in the pathogenesis of PBC. Serologically, specific AMA production occurs in all mice, and histologic hepatic lesions typical of PBC (lymphocytic infiltration, interlobular bile duct destruction, and granuloma formation in the portal tract) appear at an increased frequency. Immune infiltrating cells (including B cells, plasmacytoid dendritic cells, natural killer (NK) cells, and macrophages), CD4+ cells, and CD8+ T cells are found in the portal tracts. In IL-2Rα−/− mice (43), the IL-2 signal, which is important for controlling the fate of mature T cells, is functionally blocked. These mice develop an inflammatory bowel disease and an autoimmune lymphoproliferative disease. Anti-PDC-E2 antibodies are present in the sera of all IL-2Rα−/− mice. There is increased lymphocytic infiltration in the portal tract and damage of the interlobular bile duct. CD8+ T cells are predominant among the infiltrating lymphocytes, and there is an increase in the number of CD4+ T and B cells. In addition, a small number of granulomas is formed. Increased levels of inflammatory cytokines, including TNF-α, IFN-γ, IL-12p40, and IL-6, are also observed. Using a model produced by crossing IL-2Rα−/− mice with CD4 KO and CD8 KO mice, Hsu et al. (44) showed that CD8+ T cells participate in the pathogenesis of PBC.
XENOBIOTIC INDUCED PBC
The autoantigens of the E2 enzymes have a common structure consisting of a single N-terminal catalytic domain, containing two binding sites for the covalently attached lipoic acid cofactor. These lipoyl binding domains are the epitopes that are recognizised most often by AMAs (8) , suggesting an essential role of the lipoic acid domain in the etiology of PBC. The immune reactivity of AMAs are directed against a conformational epitope that is susceptible to chemical modification. This finding indicates that self-tolerance may be interrupted by chemical modification of the lipoyl domain of PDC-E2 by xenobiotics. It has been demonstrated that the modified lipoyl domain of PDC-E2 specifically binds antibodies in PBC sera, often at levels higher than the native PDC-E2 molecule (45) (46) (47) . These mimicking effects are found in compounds that are widely used in the environment (including perfumes, lipstick, and many common food flavorings) (45) . Studies have shown that animals immunised with selected AMApositive xenobiotics resulted in AMAs; these animals developed liver pathology similar to PBC (48; 49) .
It has been reported that B6 and NOD.1101 (NOD. B6 Idd10 Idd18r2) mice immunised with 2-octynoic acid (2-OA), coupled to BSA, had high AMA titers, portal inflammation, and cholangitis similar to human PBC (14) .
We used this xenobiotic induced PBC model to explore, in detail, the histological characteristics of the liver.
EXPERIMENTAL PROTOCOL
Female C57BL/6 mice were maintained at the animal facilities of the Faculty of Medical Sciences University of Kragujevac. All animal procedures were approved by the ethical committee of the Faculty of Medical Sciences, University of Kragujevac.
Primary biliary cirrhosis was induced as previusly described (14) . Briefly, a mixture of BSA conjugated 2-octynoic acid (2OA-BSA; 100 μg/100 μL in PBS) was injected intraperitoneally with Complete Freund's Adjuvant (CFA; Sigma-Aldrich, St. Louis, MO), containing 1 mg/mL of Mycobacterium tuberculosis (strain H37 RA; Difco Laboratories, Detroit, MI). This was subsequently boosted every two weeks with 2OA-BSA in Incomplete Freund's Adjuvant (IFA; Sigma-Aldrich, St. Louis, MO). Additionally, mice intraperitoneally received 100 ng of pertussis toxin (List Biological Laboratories, Campbell, CA) at the time of initial immunisation with 2OA-BSA in Complete Freund's Adjuvant.
Immediately following sacrifice, liver tissue was harvested, fixed in 10% buffered formalin, embedded in paraffin, and cut into 4-μm sections for routine hematoxylin and eosin (H&E) staining. Evaluation under light microscopy and scoring of liver inflammation and bile duct damage was performed on coded H&E-stained sections in a blinded fashion. The images were captured with a light microscope (Olympus) equipped with a digital camera.
Sections were evaluated for periportal inflammation, infiltration of bile ducts without damage, infiltration and damage of bile ducts, and subcapsular infiltrates. Based on the level of pathology, the indices were scored as 0, no; 1, mild; 2, moderate; 3, severe; or 4, very severe pathology. Score I was calculated as the mean value of each scored index. Granulomas, and fibrosis were scored as 0, no; 1, mild; 2, moderate; or 3, severe pathology; ,based on these values, score II was calculated.
All mice immunised with 2OA-BSA (9/9) developed histological findings typical of PBC (Figure 1 ). Our histological scoring clearly demonstrates the disease in the group of 2OA-BSA immunised mice (Figure 2) .
The autoimmune cholangitis induced by 2OA-BSA immunisation recapitulates the histological features of human PBC: portal-tract inflammation with destruction bile ducts, focal-duct obliteration with granuloma formation, periportal extension of inflammation, and fibrosis. Importantly this model of autoimmune cholangitis gives us the opportunity to study the early events of PBC pathogenesis and to explore the possibility of new PBC therapeutics.
